Index
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Blood
1.2.3 Semen
1.2.4 Urine
1.3 Market by Application
1.3.1 Global Prostate Specific Antigen (PSA) Biomarker Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Perspective (2019-2030)
2.2 Prostate Specific Antigen (PSA) Biomarker Growth Trends by Region
2.2.1 Global Prostate Specific Antigen (PSA) Biomarker Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Region (2019-2024)
2.2.3 Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Region (2025-2030)
2.3 Prostate Specific Antigen (PSA) Biomarker Market Dynamics
2.3.1 Prostate Specific Antigen (PSA) Biomarker Industry Trends
2.3.2 Prostate Specific Antigen (PSA) Biomarker Market Drivers
2.3.3 Prostate Specific Antigen (PSA) Biomarker Market Challenges
2.3.4 Prostate Specific Antigen (PSA) Biomarker Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue
3.1.1 Global Top Prostate Specific Antigen (PSA) Biomarker Players by Revenue (2019-2024)
3.1.2 Global Prostate Specific Antigen (PSA) Biomarker Revenue Market Share by Players (2019-2024)
3.2 Global Prostate Specific Antigen (PSA) Biomarker Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Prostate Specific Antigen (PSA) Biomarker Revenue
3.4 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio
3.4.1 Global Prostate Specific Antigen (PSA) Biomarker Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prostate Specific Antigen (PSA) Biomarker Revenue in 2023
3.5 Prostate Specific Antigen (PSA) Biomarker Key Players Head office and Area Served
3.6 Key Players Prostate Specific Antigen (PSA) Biomarker Product Solution and Service
3.7 Date of Enter into Prostate Specific Antigen (PSA) Biomarker Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Type
4.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Type (2019-2024)
4.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Type (2025-2030)
5 Prostate Specific Antigen (PSA) Biomarker Breakdown Data by Application
5.1 Global Prostate Specific Antigen (PSA) Biomarker Historic Market Size by Application (2019-2024)
5.2 Global Prostate Specific Antigen (PSA) Biomarker Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
6.2 North America Prostate Specific Antigen (PSA) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
6.4 North America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
7.2 Europe Prostate Specific Antigen (PSA) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
7.4 Europe Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
8.2 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2019-2024)
8.4 Asia-Pacific Prostate Specific Antigen (PSA) Biomarker Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
9.2 Latin America Prostate Specific Antigen (PSA) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
9.4 Latin America Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size (2019-2030)
10.2 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2019-2024)
10.4 Middle East & Africa Prostate Specific Antigen (PSA) Biomarker Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Detail
11.1.2 Abbott Business Overview
11.1.3 Abbott Prostate Specific Antigen (PSA) Biomarker Introduction
11.1.4 Abbott Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.1.5 Abbott Recent Development
11.2 Siemens Healthcare
11.2.1 Siemens Healthcare Company Detail
11.2.2 Siemens Healthcare Business Overview
11.2.3 Siemens Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
11.2.4 Siemens Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.2.5 Siemens Healthcare Recent Development
11.3 DiaSorin
11.3.1 DiaSorin Company Detail
11.3.2 DiaSorin Business Overview
11.3.3 DiaSorin Prostate Specific Antigen (PSA) Biomarker Introduction
11.3.4 DiaSorin Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.3.5 DiaSorin Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Prostate Specific Antigen (PSA) Biomarker Introduction
11.4.4 Roche Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Tosoh Bioscience
11.5.1 Tosoh Bioscience Company Detail
11.5.2 Tosoh Bioscience Business Overview
11.5.3 Tosoh Bioscience Prostate Specific Antigen (PSA) Biomarker Introduction
11.5.4 Tosoh Bioscience Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.5.5 Tosoh Bioscience Recent Development
11.6 Fujirebio
11.6.1 Fujirebio Company Detail
11.6.2 Fujirebio Business Overview
11.6.3 Fujirebio Prostate Specific Antigen (PSA) Biomarker Introduction
11.6.4 Fujirebio Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.6.5 Fujirebio Recent Development
11.7 BodiTech
11.7.1 BodiTech Company Detail
11.7.2 BodiTech Business Overview
11.7.3 BodiTech Prostate Specific Antigen (PSA) Biomarker Introduction
11.7.4 BodiTech Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.7.5 BodiTech Recent Development
11.8 GE Healthcare
11.8.1 GE Healthcare Company Detail
11.8.2 GE Healthcare Business Overview
11.8.3 GE Healthcare Prostate Specific Antigen (PSA) Biomarker Introduction
11.8.4 GE Healthcare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.8.5 GE Healthcare Recent Development
11.9 Endocare
11.9.1 Endocare Company Detail
11.9.2 Endocare Business Overview
11.9.3 Endocare Prostate Specific Antigen (PSA) Biomarker Introduction
11.9.4 Endocare Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.9.5 Endocare Recent Development
11.10 Quest Diagnostics
11.10.1 Quest Diagnostics Company Detail
11.10.2 Quest Diagnostics Business Overview
11.10.3 Quest Diagnostics Prostate Specific Antigen (PSA) Biomarker Introduction
11.10.4 Quest Diagnostics Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.10.5 Quest Diagnostics Recent Development
11.11 Bio-Rad Laboratories
11.11.1 Bio-Rad Laboratories Company Detail
11.11.2 Bio-Rad Laboratories Business Overview
11.11.3 Bio-Rad Laboratories Prostate Specific Antigen (PSA) Biomarker Introduction
11.11.4 Bio-Rad Laboratories Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.11.5 Bio-Rad Laboratories Recent Development
11.12 QIAGEN
11.12.1 QIAGEN Company Detail
11.12.2 QIAGEN Business Overview
11.12.3 QIAGEN Prostate Specific Antigen (PSA) Biomarker Introduction
11.12.4 QIAGEN Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.12.5 QIAGEN Recent Development
11.13 Myriad RBM
11.13.1 Myriad RBM Company Detail
11.13.2 Myriad RBM Business Overview
11.13.3 Myriad RBM Prostate Specific Antigen (PSA) Biomarker Introduction
11.13.4 Myriad RBM Revenue in Prostate Specific Antigen (PSA) Biomarker Business (2019-2024)
11.13.5 Myriad RBM Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details